Back to results
US 2006/0140962 A1Published application
Combination treatment of pancreatic cancer
OwnerPhilip Gevas, Dov Michaeli +2inventors
InventorsPhilip Gevas, Dov Michaeli, Stephen Grimes, Martyn Caplin
Life of this patent
Estimating the term…
Abstract
A combination for use in the treatment of pancreatic cancer comprising: (i) an anti-gastrin effective immunogenic composition; and, (ii) one or more chemotherapeutic agents suitable for inhibiting cancer growth.
Claims19
A combination for use in the treatment of pancreatic cancer comprising:
- (i) an anti-gastrin effective immunogenic composition;
- and
- (ii) one or more chemotherapeutic agents suitable for inhibiting cancer growth.
A combination for use in the treatment of pancreatic cancer comprising:
- (i) an anti-gastrin and/or anti-gastrin receptor effective immunological agent which can be monoclonal antibody or polyclonal antibodies derived from antisera produced in a patient by immunization with an anti-gastrin immunogenic composition;
- and
- (ii) one or more chemotherapeutic agents suitable for inhibiting cancer growth.
(canceled)
A method for treating pancreatic cancer comprising administering a gastrin-immunoneutralizing immunogenic composition;
- and administering a pharmaceutical composition of one or more chemotherapeutic agent effective for inhibiting cancer growth.
Dependencies are inferred from the claim text.